Systematic review with meta-analysis: autoimmune hepatitis in pregnancy

References

• Chen J, Eslick GD, Weltman M. Systematic review with Meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly. Aliment Pharmacol Ther. 2014;39(2):117–124.
   PubMed Web of Science ®Google Scholar
• Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World J Gastroenterol. 2017;23(33):6030–6048.
   PubMed Web of Science ®Google Scholar
• Kothadia JP, Shah JM. Autoimmune hepatitis and pregnancy. Treasure Island (FL): StatPearls Publishing; 2020.
   Google Scholar
• Ma K, Berger D, Reau N. Liver diseases during pregnancy. Clin Liver Dis. 2019;23(2):345–361.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. Jama. 2000;283(15):2008–2012.
   PubMed Web of Science ®Google Scholar
• Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929–938.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. 2013 [cited 2009 Oct 19]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
   Google Scholar
• Moga C, Guo B, Schopflocher D, et al. Development of a quality appraisal tool for case series studies using a modified delphi technique. Edmonton (AB): Institute of Health Economics; 2012.
   Google Scholar
• McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments. Res Syn Meth. 2021;12(1):55–61.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, GRADE Working Group, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Schroll J, Moustgaard R, Gøtzsche P. Dealing with substantial heterogeneity in cochrane reviews. Cross-sectional study. BMC Med Res Methodol. 2011;11(1):22.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Stokkeland K, Ludvigsson J, Hultcrantz R, et al. Increased risk of preterm birth in women with autoimmune hepatitis - a nationwide cohort study. Liver Int. 2016;36(1):76–83.
   PubMed Web of Science ®Google Scholar
• Werner M, Björnsson E, Prytz H, et al. Autoimmune hepatitis among fertile women: Strategies during pregnancy and breastfeeding? Scand J Gastroenterol. 2007;42(8):986–991.
   PubMed Web of Science ®Google Scholar
• Llovet L, Horta D, Eliz M, et al. Presentation and outcomes of pregnancy in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol. 2019;17(13):2819–2821.
   PubMed Web of Science ®Google Scholar
• Westbrook R, Yeoman A, Kriese S, et al. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun. 2012;38(2–3):J239–J244.
   PubMed Web of Science ®Google Scholar
• Terrabuio D, Abrantes-Lemos C, Carrilho F, et al. Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. J Clin Gastroenterol. 2009;43(4):350–356.
   PubMed Web of Science ®Google Scholar
• Samuel D, Riordan S, Strasser S, et al. Severe autoimmune hepatitis first presenting in the early post partum period. Clin Gastroenterol Hepatol. 2004;2(7):622–624.
   PubMed Web of Science ®Google Scholar
• Izumi Y, Kaneko A, Oku K, et al. Development of liver dysfunction after delivery is possibly due to postpartum autoimmune hepatitis. A report of three cases. J Intern Med. 2002;252(4):361–367.
   PubMed Web of Science ®Google Scholar
• Aggarwal N, Chopra S, Suri V, et al. Pregnancy outcome in women with autoimmune hepatitis. Arch Gynecol Obstet. 2011;284(1):19–23.
   PubMed Web of Science ®Google Scholar
• Efe C, Purnak T, Ozaslan E. Autoimmune hepatitis in the postpartum period. Clin Res Hepatol Gastroenterol. 2012;36(4):391–393.
   PubMed Web of Science ®Google Scholar
• Colle I, Hautekeete M. Remission of autoimmune hepatitis during pregnancy: a report of two cases. Liver International. 1999;19(1):55–57.
   Web of Science ®Google Scholar
• Grønbaek L, Vilstrup H, Jepsen P. Pregnancy and birth outcomes in a danish nationwide cohort of women with autoimmune hepatitis and matched population controls. Aliment Pharmacol Ther. 2018;48(6):655–663.
   PubMed Web of Science ®Google Scholar
• Schramm C, Herkel J, Beuers U, et al. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterology. 2006;101(3):556–560.
   PubMed Web of Science ®Google Scholar
• Danielsson Borssén Å, Wallerstedt S, Nyhlin N, et al. Pregnancy and childbirth in women with autoimmune hepatitis is safe, even in compensated cirrhosis. Scand J Gastroenterol. 2016;51(4):479–485.
   PubMed Web of Science ®Google Scholar
• Wang C, Grab JD, Tana MM, et al. Outcomes of pregnancy in autoimmune hepatitis: A population-based study. Hepatology. Conference: 71st Annual Meeting of the American Association for the Study of Liver Diseases, AASLD. Boston, MA United States. 72 (1 SUPPL) (pp 73A-74A), 2020. Date of Publication: November 2020.
   Google Scholar
• Alexander S, Wildman K, Zhang W, et al. Maternal health outcomes in Europe. Euro J Obstetr Gynecol Reproduc Biol. 2003;111:S78–S87.
   PubMed Web of Science ®Google Scholar
• Faulkes R, Chauhan A, Knox E, et al. Review article: chronic liver disease and pregnancy. Aliment Pharmacol Ther. 2020;52(3):420–429.
   PubMed Web of Science ®Google Scholar
• de Sousa G, Prinz N, Becker M, et al. Diabetes mellitus and autoimmune hepatitis: Demographical and clinical description of a relatively rare phenotype. Horm Metab Res. 2018;50(07):568–574.
   PubMed Web of Science ®Google Scholar
• EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63(4):971–1004.
   PubMed Web of Science ®Google Scholar
• van den Brand F, van der Veen K, Lissenberg-Witte B, de Boer Y, van Hoek B, Drenth J, et al.; Dutch Autoimmune Hepatitis Study Group. Adverse events related to low dose corticosteroids in autoimmune hepatitis. Aliment Pharmacol Ther. 2019;50(10):1120–1126.
   PubMed Web of Science ®Google Scholar
• Alexander S, Wildman K, Zhang W, et al. Maternal health outcomes in Europe. Euro J Obstetr Gynecol Reproduc Biol. 2003;111:S78–S87.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–S31. PMID: 31862745.
   PubMed Web of Science ®Google Scholar
• Wolf VL, Ryan MJ. Autoimmune Disease-Associated hypertension. Curr Hypertens Rep. 2019; 21(1):10.
   PubMed Web of Science ®Google Scholar
• Panoulas VF, Douglas KM, Milionis HJ, et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford)). 2007;46(9):1477–1482.
   PubMed Web of Science ®Google Scholar
• Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829–835.
   PubMed Web of Science ®Google Scholar
• Zeitlin J, Mortensen L, Cuttini M, Lack N, Nijhuis J, Haidinger G, et al.; Euro-Peristat Scientific Committee. Declines in stillbirth and neonatal mortality rates in Europe between 2004 and 2010: results from the Euro-Peristat project. J Epidemiol Community Health. 2016;70(6):609–615.
   PubMed Web of Science ®Google Scholar
• Lopez-Delgado JC, Ballus J, Esteve F, et al. Outcomes of abdominal surgery in patients with liver cirrhosis. World J Gastroenterol. 2016;22(9):2657–2667.
   PubMed Web of Science ®Google Scholar
• Akbari M, Shah S, Velayos FS, et al. Systematic review and Meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(1):15–22.
   PubMed Web of Science ®Google Scholar
• Mozaffari S, Abdolghaffari A, Nikfar S, et al. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis. Hum Exp Toxicol. 2015;34(5):445–459.
   PubMed Web of Science ®Google Scholar
• Hutson J, Matlow J, Moretti M, et al. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. J Obstet Gynaecol. 2013;33(1):1–8.
   PubMedGoogle Scholar
• Tran TT, Ahn J, Reau NS. ACG clinical guideline: liver disease and pregnancy. Am J Gastroenterol. 2016;111(2):176–194. Febquiz 196.
   PubMed Web of Science ®Google Scholar
• Bennett AL, Mamunes A, Kim M, et al. Mo1867 – the importance of monitoring the postpartum period in moderate to severe crohn’s disease. Gastroenterology. 2019;156(6):S-869.
   Web of Science ®Google Scholar
• Yu A, Friedman S, Ananthakrishnan AN. Incidence and predictors of flares in the postpartum year among women with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26(12):1926–1932.
   PubMed Web of Science ®Google Scholar
• Ngu JH, Bechly K, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol. 2010;25(10):1681–1686.
   PubMed Web of Science ®Google Scholar